Conference: New Understanding Of Genetic Haemochromatosis

CPD Accreditation Logo

This event is CPD accredited 5 Units

This event was held on Friday 31 March 2017. A report on the highly successful and informative day will be posted here shortly.

The Haemochromatosis Society is delighted to announce a specialist one-day scientific/medical CPD accredited conference exploring and debating new understandings of the pathology, diagnosis and management of genetic haemochromatosis.

This event is supported by Resonance Health.

This important event, the first for many years in the UK focusing on genetic haemochromatosis, will encompass:

  • The role of transferrin saturation as a diagnostic and monitoring tool
  • Arthropathy and haemochromatosis (The Fernau Lecture)
  • MRI technology in the diagnosis of iron overload
  • Advances in our understanding of the genetics of haemochromatosis

The event, New Understanding of Genetic Haemochromatosis, will be held on 31 March 2017 in central Birmingham, just a few minutes from New Street (Grand Central) station.

New Understanding of Genetic Haemochromatosis is aimed at clinicians and scientists alike. Those that should attend include:

  • haematologists
  • gastroenterologists
  • hepatologists
  • rheumatologists
  • general practitioners
  • lead venesection clinicians
  • others involved in the clinical care of GH patients
  • pathologists
  • other scientists with an interest in the pathology of iron overload

Four very important topics will be discussed during the day, with presentations from highly respected speakers in each field.


CPD accreditation has been approved for 5 units (hours) of education time by The Royal College of Pathologists. Medical staff and clinical scientists in career grade posts who are enrolled with one of the Royal Colleges for CPD purposes and attend the meeting will be entitled to these credits.

Early Booking

Early booking is recommended. This page will be updated with speaker biographies and more information as it becomes available. In the meantime you can secure your place at this important GH event in either of 2 ways:

The Haemochromatosis Society can raise an invoice for your institution or NHS Trust.

The delegate fee, including conference attendance, subsequent password access to recordings and presentations, refreshments and lunch, is just £100.00. The society is not registered for VAT.


A bursary scheme kindly funded by Perspectum Diagnostics enables students of relevant disciplines and clinicians on lower pay grades to secure places at the event at a 50% discount. To apply for a bursary place (which must be approved before booking) please email with your name, job title, contact details, professional interest and reason for applying for the price reduction. Bursary places are limited.

Speaker Biographies

Speakers are listed in the programme below. Biographies will be posted here shortly.


The venue for the event is the Novotel Hotel and Conference Centre, Broad Street, Birmingham. This is a modern conference venue with all the usual facilities. The event is held on the ground floor with all areas on one level.

The venue is a few minutes walk or a short taxi ride from Birmingham’s New Street (Grand Central) Station. Parking is available in the NCP car park to the rear of the building.

For full venue details and map please visit the venue website at this link.


0900 Coffee and registration
1000 – 1015 Welcome

Mr Howard Don, Chair, The Hemochromatosis Society

Introductions and Conference Chair’s Opening Remarks

Dr Edward (Ted) Fitzsimons
Event Chair
Consultant Haematologist, NHS Greater Glasgow & Clyde, Glasgow, Scotland
Honorary Clinical Associate Professor (School of Medicine, Dentistry and Nursing), University of Glasgow

1015 – 1115 The Role of Transferrin Saturation in the Pre-emption, Diagnosis and Management of Genetic Haemochromatosis: Contrasting Views and Debate

Prof. Pierre Brissot
Professor of Hepatology
Former head of the French Reference Center for Rare Genetic Iron Overload Diseases
University Hospital, Pontchaillou, Rennes, France

Prof. John Porter
Professor of Haematology and Consultant Haematologist
University College London Hospitals, London, UK
Head of the Joint Red Cell Unit for UCLH and Whittington Hospitals

1115 – 1130 Comfort Break
1130 – 1215 The Fernau Lecture (Inaugural)

The Fernau Lecture is given in honour of the founders of The Haemochromatosis Society, Mr Guy and Mrs Janet Fernau. This inaugural lecture is entitled “Arthropathy as a marker for the early diagnosis of genetic haemochromatosis – a patient study”

Dr Patrick Kiely BSc MB BS FRCP PhD
Consultant Rheumatologist
St George’s Healthcare NHS Trust, St George’s Hospital, London, UK

Followed by a Q&A opportunity

1215 – 1315 Lunch
1315 – 1445 MRI Technology and Genetic Haemochromatosis

The Development of MRI technology as applied to Genetic Haemochromatosis

Prof. Tim St Pierre BSc PhD
University of Western Australia, Perth, Australia
Chief Medical Officer
Resonance Healthcare, Perth, Australia

The clinical application of MRI technology

Dr Barbara Butzeck
(details follow)

The impact of MRI Technology as a Diagnostic Tool in GH

Dr Rajarshi Banerjee
(details follow)

1445 – 1515 Tea Break
1515 – 1615 The Digenic / Multigenic Nature of Iron Overload: Thinking Beyond C282Y and H63D

Dr Kathryn Robson and Dr Patricia Bignell
(details follow)

The GH Patient Pathway Through the NHS Blood Service

Dr Naim Akhtar
Clinical Support Team
NHS Blood & Transplant

1615 – 1645 Questions and Answers to the Speakers
Chair’s Closing Remarks and Summary
Dr Edward (Ted) Fitzsimons
Event Chair
1645 Event Close
1645 – 1800 Drinks Reception

Note that this programme may be amended due to changes beyond our control.

Secure your place now:

The Haemochromatosis Society can raise an invoice for your institution or NHS Trust.

Commercial Sponsorship

We are grateful for financial support from Resonance Health who are making a contribution to the administrative costs of the conference and funding the expenses for speakers Prof. Tim St Pierre and Dr Barbara Butzek. We are grateful too that the bursary scheme is being funded by Perspectum Diagnostics. There is no other financial relationship between either company and The Haemochromatosis Society.